Código QR (código de barras bidimensional)

Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report

<b>Background:</b> Statin intolerance is a serious therapeutic dilemma in secondary cardiovascular prevention (e.g., ESC/EAS Guidelines 2023). This is especially true when confirmed by genetic predisposition and complicated by rhabdomyolysis. Although several non-statin agents have become available...

Fuld beskrivelse

Na minha lista:
Principais autores: Jozef Dodulík, Jiří Plášek, Ivana Kacířová, Romana Uřinovská, Jiří Vrtal, Jan Václavík
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2025-05-01
Serier:Pharmaceuticals
Fag:
statin intolerance
rhabdomyolysis
inclisiran
bempedoic acid
ezetimibe
genetic testing
Online adgang:https://www.mdpi.com/1424-8247/18/6/818
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker